← Back

MarketAxess Holdings Inc

MarketAxess Holdings Inc., together with its subsidiaries, operates an electronic trading platform for institutional investor and broker-dealer firms in the United States, the United Kingdom, and internationally. The company offers trading technology to access liquidity on its platforms in U.S. high-grade bonds, U.S. high-yield bonds, emerging market debt, eurobonds, municipal bonds, U.S. government bonds, and other fixed-income securities; and executes bond trades between and among institutional investor and broker-dealer clients in an all-to-all anonymous trading environment for corporate bonds through its Open Trading protocols. It also provides automated and algorithmic trading solutions, such as X-Pro, a trading platform to combine trading protocols with its proprietary data and pre-trade analytics; and integrated and actionable data offerings, including CP+ and Axess All, a real-time pricing engine, including Auto-X and portfolio trading. In addition, the company offers various pre-and post-trade services, such as processing, trade matching, trade publication, regulatory transaction reporting, and market and reference data across a range of fixed-income and other products. The company was incorporated in 2000 and is headquartered in New York, New York.

Price · split & dividend adjusted
News & notes moving MKTX
MKTX

Monteverde & Associates investigates four mergers for potential shareholder claims

Monteverde & Associates PC is investigating four proposed acquisitions for potential breaches of fiduciary duty and other violations of law. The firm is examining the sale of Forte Biosciences to argenx BV at $77.00 per share in cash, Luxfer Holdings to affiliates of Wynnchurch Capital at $17.37 per share in cash, Sanara MedTech to MiMedx Group for $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share, and MarketAxess Holdings to Intercontinental Exchange at $167.00 per share in cash. Shareholders are encouraged to contact the firm before the applicable tender offer deadlines, including August 26, 2026 for Forte Biosciences.
GlobeNewswire·20dRead more ▾
MKTX

Wohl & Fruchter investigates fairness of MarketAxess sale to ICE

The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of MarketAxess Holdings Inc. to Intercontinental Exchange, Inc. Under the deal, MarketAxess shareholders would receive $167.00 per share in cash. The firm notes that this price is well below MarketAxess’ 52-week high of $200.90 per share, and that UBS analyst Alex Kramm set a $200.00 price target on July 8, 2026. Several shareholders on Seeking Alpha have expressed concerns, with one calling the bid a low ball offer and another accusing management of selling the company too cheaply. Wohl & Fruchter is examining whether the MarketAxess Board acted in shareholders’ best interests and whether all material information has been disclosed.
GlobeNewswire·20dRead more ▾
MKTX2

Halper Sadeh LLC Investigates Fairness of Deals for FBRX, LXFR, SMTI, MKTX

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Forte Biosciences, Luxfer Holdings, Sanara MedTech, and MarketAxess Holdings are fair to shareholders. The firm is examining Forte Biosciences' sale to argenx for $77.00 per share in cash, Luxfer Holdings' sale to affiliates of Wynnchurch Capital for $17.37 per ordinary share in cash, Sanara MedTech's sale to MiMedx Group for $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share, and MarketAxess Holdings' sale to Intercontinental Exchange for $167.00 per share in cash. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages affected investors to contact the firm to discuss their legal rights and options at no cost.
GlobeNewswire·21dRead more ▾
MKTX

Brodsky & Smith investigates boards of MarketAxess, CBIZ, Sanara MedTech, and TriCo Bancshares over merger deals

Brodsky & Smith is investigating the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares for potential breaches of fiduciary duty in connection with their respective merger agreements. The investigations concern whether the boards failed to conduct a fair process and whether the proposed transactions pay fair value to shareholders. MarketAxess is being acquired by Intercontinental Exchange for $167 per share in cash, representing an equity value of approximately $6.0 billion. CBIZ is being acquired by Grant Thornton Advisors for $55.00 per share in an all-cash deal with an enterprise value of $5 billion. Sanara MedTech is being acquired by MiMedx Group in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. TriCo Bancshares is being acquired by First Hawaiian in an all-stock deal where TriCo shareholders will receive 2.095 First Hawaiian shares for each TriCo share, representing $63.12 per share based on First Hawaiian's closing price on July 10, 2026.
GlobeNewswire·22dRead more ▾
Biotech & Genomic Medicineimpact 4

KKR nears Integer Holdings buyout, ICE to acquire MarketAxess in $6 billion deal

Several major deals were reported this week across sectors. KKR is close to a deal to take medical-device outsourcer Integer Holdings private, sending its shares up 20%. Intercontinental Exchange agreed to acquire fixed-income electronic trading platform MarketAxess Holdings in a transaction valuing its equity at roughly $6.0 billion and total enterprise at $5.7 billion. Grant Thornton Advisors agreed to buy professional services firm CBIZ in an all-cash deal with a $5 billion enterprise value, backed by New Mountain Capital. Koch Inc. is exploring a sale of data center developer Edged that could value it at more than $15 billion. KKR and Energy Capital Partners agreed to acquire Ireland-based energy distributor DCC Energy in a deal valued at about £5.7 billion, with shareholders receiving £65.25 per share in cash plus a final dividend and a potential contingent payment. TransDigm Group agreed to acquire Prince & Izant from Industrial Growth Partners for approximately $1.066 billion in cash. argenx SE will acquire Forte Biosciences for $77 per share in cash, a transaction valued at roughly $2.2 billion, adding a first-in-class anti-CD122 antibody to its immunology portfolio. Ambarella shares surged 19% on a report that NXP Semiconductors is in talks to acquire the chip designer, though a deal is not certain. Curium is in advanced talks to buy radiopharma company Lantheus Holdings for about $102 per share upfront plus $12.50 per share in contingent value rights.
Seeking Alpha·24dRead more ▾
MKTX

Financial stocks fall amid earnings as bond sell-off pushes 30-year Treasury yield to highest level in nearly two decades

Financial stocks declined this week as the bond market sell-off intensified, with the 30-year Treasury yield climbing to its highest recorded level in nearly two decades after the Federal Reserve held rates steady. The State Street Financial Select Sector SPDR ETF dropped 1.12% to $56.94, while Goldman Sachs fell 4.04% to $1,018.38 and Robinhood Markets slid 8.80% to $86.56 despite strong quarterly results. Among gainers, Mastercard advanced 6.20% to $573.10 on better-than-expected earnings, and European banks extended their rally following strong reports from Deutsche Bank and UBS. MarketAxess Holdings surged 39.09% to $162.30 after beating estimates and agreeing to be acquired by Intercontinental Exchange in a deal valuing its equity at approximately $6.0 billion.
Seeking Alpha·25dRead more ▾
Digital Finance & Tokenization4impact 4

MarketAxess Soars 29% on $6 Billion Intercontinental Exchange Buyout at 33% Premium

MarketAxess Holdings shares surged 29.45 percent to close at $162.76 on Thursday after the company agreed to be acquired by Intercontinental Exchange for $6 billion, representing a 33 percent premium over its prior closing price. The definitive agreement values all outstanding shares at $167 each, though the closing price of $162 suggests investors see limited additional upside before the deal completes. The transaction has been approved by both companies' boards and is expected to close in the first half of 2027, pending regulatory and shareholder approvals. The merger aims to create a fully integrated global fixed-income platform spanning pre-trade analytics, multi-protocol electronic execution for retail and institutional clients, and post-trade data and compliance tools. The announcement followed MarketAxess's second-quarter earnings, which showed net income fell 4 percent to $68 million on flat revenues of $218 million, as a 3 percent decline in total commission revenues and a 9 percent drop in US credit offset a 6 percent rise in emerging markets commission and a record 14 percent increase in service revenues to $31.5 million. Separately, the board declared a quarterly dividend of $0.78 per share payable on September 2 to shareholders of record as of August 19, 2026. Hedge fund interest held steady with 42 firms holding positions in the first quarter, while institutional conviction edged up to $1.523 billion from $1.518 billion.
Insider Monkey·27dRead more ▾
MKTXimpact 4

Meta and Microsoft lead midday stock swings on earnings surprises

Meta Platforms tumbled more than 9% after posting quarterly earnings per share of $6.18, missing analysts' estimates by $1.04 per share, while Microsoft jumped 15% on revenue of $90.01 billion that topped expectations. MarketAxess surged 30% after Intercontinental Exchange agreed to buy the bond trading platform for $167 per share in a deal valued at more than $5 billion. Crocs dropped more than 10% despite beating fiscal second-quarter expectations and raising its forecast, as margins came in weaker than expected. Other notable movers included Quanta Services up nearly 15% on strong results, Fair Isaac plunging more than 16% on mixed results and a delayed direct license program, and Teladoc Health sinking 29% after missing revenue estimates and lowering guidance.
CNBC·27dRead more ▾
MKTX

MarketAxess Q2 revenue dips 0.5% to $218.42 million, beats estimates

MarketAxess reported second-quarter revenue of $218.42 million, a 0.5% decline from the prior year but slightly above the Zacks Consensus Estimate of $217.34 million. Earnings per share came in at $1.95, compared to $2.00 a year ago and surpassing the consensus estimate of $1.88. Total average daily volume reached $43.07 billion, below the $45.87 billion analysts had projected, with credit trading average daily volume of $16.85 billion and rates trading average daily volume of $26.22 billion. Commission revenue fell 2.5% to $186.9 million, while information services revenue rose 23% to $16.09 million, post-trade services revenue increased 4.7% to $11.6 million, and technology services revenue grew 8.5% to $3.83 million.
Zacks Investment Research·27dRead more ▾
Cloud & Digital Infrastructureimpact 4

Meta and Microsoft lead premarket swings after quarterly results

Several major companies saw sharp premarket moves following their latest earnings reports. Microsoft jumped 9% after quarterly revenue of $90.01 billion beat the $87.62 billion estimate, with Azure growth of 43% at constant currency exceeding expectations and Azure revenue surpassing $100 billion for the first time in the 2026 fiscal year. Meta Platforms tumbled nearly 9% after earnings per share of $6.18 missed estimates by $1.04 and its third-quarter revenue forecast of $61 billion to $64 billion came in light at the lower end. Teladoc Health plunged 18.5% on a revenue miss and lowered full-year guidance, while Norwegian Cruise Line fell 7% after cutting its full-year earnings forecast to $1.50 per share. Starbucks rose 6% on raised full-year outlook and same-store sales growth of 7.9%, and Fortinet soared 12% on strong billings and an upbeat third-quarter forecast. MarketAxess shares were halted on news of its acquisition by Intercontinental Exchange for $167 per share in a deal valued at more than $5 billion.
CNBC·27dRead more ▾
MKTX

Heartland Mid Cap Value Fund Remains Confident in MarketAxess Despite Detracting Performance

Heartland Mid Cap Value Fund disclosed that MarketAxess Holdings was its biggest performance detractor in the second quarter of 2026, yet the fund remains confident in the position. The fund initiated the stake in the first quarter and added to it in the second, citing MarketAxess's status as the largest U.S. corporate bond electronic trading platform. It highlighted the company's exit from a heavy investment cycle, market share gains in a key U.S. credit trading protocol, and scale advantages in international markets where electronic trading penetration is low. The fund also noted a compelling valuation at 8.8 times consensus 2026 enterprise value to EBITDA versus a domestic peer median of 14.0 times, and a free cash flow yield exceeding 8%. MarketAxess shares closed at $114.87 on July 14, 2026, with a one-month return of negative 4.20% and a 52-week decline of 46.70%, giving it a market capitalization of $4.08 billion.
Insider Monkey·42dRead more ▾
MKTX

MarketAxess Stock May Be 39% Undervalued on TraX Tape Launch

MarketAxess Holdings stock may be about 39% undervalued relative to its intrinsic value estimate from the Excess Returns model, even as its share price has fallen roughly 72.5% over the past five years. The model uses a book value of $33.49 per share and stable earnings per share of $9.98 against a cost of equity of $3.34 per share, yielding an excess return of $6.63 per share and an intrinsic value of about $193.65 per share, compared with the current price around $118.60. The recent launch of the TraX Tape data platform supports the case for stronger revenue and data monetisation, though pressure on trading volumes remains a key risk. On a price-to-earnings basis, the stock trades at around 13.6 times earnings, close to its estimated fair P/E of about 12.7 times, suggesting the market price already aligns reasonably with fundamentals. Overall, the valuation picture is mixed, with the Excess Returns model pointing to a sizeable discount while the P/E workup indicates roughly fair value.
Simply Wall St·49dRead more ▾
MKTX

MarketAxess Q2 total credit trading volume tops $1 trillion despite 11% ADV decline

MarketAxess reported that total credit trading volume on its electronic platform exceeded $1.04 trillion in the second quarter of 2026, a 1% year-over-year increase, even as total trading average daily volume fell 11% to $43.6 billion. Growth in emerging markets and agencies and other government bond rates helped offset declines in U.S. government bond rates, high-grade, and high-yield. Total credit average variable transaction fees per million declined 7% due to product and protocol mix and lower duration in U.S. high-grade, while total rates fees per million jumped 24%. The company's estimated market share of U.S. credit portfolio trading rose to 20.6% from 17.5% a year ago, and total Mid-X trading volume surged 156% to a record $23.6 billion.
Zacks Investment Research·50dRead more ▾
MKTX

Wall Street’s Favorite Stocks: PTC Touted, PVH and MarketAxess Flagged

StockStory highlights PTC as a stock to buy, citing 21% billings growth over the past year, an 84.7% gross margin, and a 38.7% operating margin. The firm flags PVH and MarketAxess as stocks facing headwinds, pointing to PVH’s weak constant currency growth and 6.4% free cash flow margin, and MarketAxess’s 4% annual revenue growth and flat earnings per share over five years. PTC trades at $112.76 per share, PVH at $72.13, and MarketAxess at $109.07.
StockStory·61dRead more ▾
MKTX

Financial Exchanges and Data Stocks Report Mixed Q1 Earnings

The ten financial exchanges and data stocks tracked by StockStory reported a satisfactory first quarter, with aggregate revenues beating analysts' consensus estimates by 1.1%. Moody's posted revenues of $2.08 billion, up 8.1% year on year and exceeding expectations by 0.9%, though its stock fell 3.4% afterward. Morningstar delivered the biggest beat among peers with revenues of $644.8 million, up 10.8% and topping estimates by 2.9%, yet its shares dropped 16.7%. CME Group was the weakest performer, with revenues of $1.88 billion missing estimates by 1.4%, and its stock declined 14.5%. MarketAxess and Nasdaq also beat revenue expectations, but their shares fell 20.7% and 4.6%, respectively, as the group's average stock price declined 8.3% since reporting.
StockStory·63dRead more ▾
MKTX

MarketAxess Q1 Revenue Rises 11.9% to $233.4 Million, Beating Estimates

MarketAxess reported first-quarter revenues of $233.4 million, up 11.9% year on year and exceeding analysts' expectations by 0.6%. The electronic bond-trading platform also delivered a solid beat on EBITDA estimates. Among the ten financial exchanges and data stocks tracked, the group overall posted a satisfactory quarter with revenues beating consensus by 1.1%, though share prices have fallen an average of 7.4% since reporting. Morningstar was the best performer against estimates with revenues of $644.8 million, up 10.8% and beating by 2.9%, while CME Group was the weakest, with revenues of $1.88 billion missing estimates by 1.4%. MarketAxess shares have declined 19.2% since the report and currently trade at $120.33.
StockStory·65dRead more ▾
Digital Finance & Tokenization2

MarketAxess launches TraX Tape to consolidate global bond trading data

MarketAxess Holdings has launched TraX Tape, a new data solution that consolidates global bond trading activity into a single standardized feed. Built on the company's TraX data network, the platform cleanses and de-duplicates information from a broad network of dealers and clients, then enriches it with trade-direction indicators, expanded visibility, and integrated analytics such as yield and spread calculations. The solution also incorporates pricing context from MarketAxess's AI-powered CP+ pricing engine. The launch comes as regulatory transparency reforms in the UK and EU increase the volume of available bond trading data, creating challenges around interpretation and usability. MarketAxess shares have declined 45.3% over the past year, compared with a 33.1% rise for the industry.
Zacks Investment Research·68dRead more ▾